Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Acting as analogs of endogenous GLP-1, GLP-1RAs have emerged as one of the most effective therapeutic options for managing T2DM due to their multifaced effects on glucose metabolism (Table 2) [73]
In 2021, the sales of Lilly's long-acting GLP-1 receptor agonist product dulaglutide were US$6.472 billion, up 49% from the previous year
Predefined sensitivity analyses to determine potential confounding influence were conducted with the same statistical analysis set-up removing (1) patients with IIH without papilledema (IIH-WOP), and (2) patients with pre-existing migraine
We have seen estimates that semaglutide may only cost around USD 10 to make a monthly dose
The publisher of this article has made every effort to ensure accuracy at the time of publication
Beyond their established role in diabetes management and growing use for obesity, the therapeutic horizon for GLP-1 RAs appears to be expanding
